Plasma concentrations of brain natriuretic peptide in patients with acute ischemic stroke

Cerebrovascular Diseases

Volumn 19, Issue 3, 2005, Pages 157-164

  Nakagawa, Kazuhiko ^a   Yamaguchi, Takekane ^a   Seida, Mitsuru ^a   Yamada, Shimpei ^a   Imae, Shogo ^a   Tanaka, Yoji ^b   Yamamoto, Kiyotaka ^c   Ohno, Kikuo ^b  

^a Toshima Tokyo Metropolitan Hospital   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

Atrial fibrillation; Brain natriuretic peptide; Cerebral infarction; Hemodynamic regulation

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; SODIUM;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ESSENTIAL HYPERTENSION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEMODYNAMICS; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SODIUM BLOOD LEVEL; ACUTE DISEASE; BLOOD; BLOOD PRESSURE; ELECTROLYTE BALANCE; HYPERTENSION; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR;

ACUTE DISEASE; AGED; ATRIAL FIBRILLATION; BLOOD PRESSURE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; RISK FACTORS; SODIUM; WATER-ELECTROLYTE BALANCE;

EID: 17444391659     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083249     Document Type: Article

References (19)

1. Levin ER, Gardner DG, Samson WK: Natriuretic peptides. N Engl J Med 1998;339:321-328.
2. Bonow RO: New insight into the cardiac natriuretic peptides. Circulation 1996;93:1946-1950.
3. Kohno M, Horio T, Yokokawa K, Murakawa K, Yasunari K, Akioka K, Tahara A, Toda I, Takeuchi K, Kurihara N, Takeda T: Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med 1992;92:29-34.
4. Rossi A, Enriquez-Sarano M, Burnett JC Jr, Lerman A, Abel MD, Seward JB: Natriuretic peptide levels in atrial fibrillation. A prospective hormonal and doppler-echocardiographic study. J Am Coll Cardiol 2000;35:1256-1262.
5. Myers MG, Norris JW, Hachinski VC, Weingert ME, Sole MJ: Cardiac sequelae of acute stroke. Stroke 1982;13:838-842.
6. Oppenheimer SM, Lima J: Neurology and the heart. J Neurol Neurosurg Psychiatry. 1998; 64:289-297.
7. Myers MG, Norris JW, Hachinski VC, Sole MJ: Plasma norepinephrine in stroke. Stroke 1981;12:200-204.
8. Wallace JD, Levy LL: Blood pressure after stroke. JAMA 1981;246:2177-2180.
9. Britton M, Carlsson A, de Faire U: Blood pressure course in patients with acute stroke and matched controls. Stroke 1986;17:861-864.
10. Tuinenburg AE, Brundel BJ, Van Gelder IC, Henning RH, Van Den Berg MP, Driessen C, Grandjean JG, Van Gilst WH, Crijns HJ: Gene expression of the natriuretic peptide system in atrial tissue of patients with paroxysmal and persistent atrial fibrillation. J Cardiovasc Electrophysiol 1999;10:827-835.
11. Inoue S, Murakami Y, Sano K, Katoh H, Shimada T: Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J Card Fail 2000;6:92-96.
12. Carberg C, Asplund K, Hagg E: Factors influencing admission blood pressure levels in patients with acute stroke. Stroke 1991;22:527-530.
13. Barron SA, Rogovski Z, Hemli J: Autonomic consequences of cerebral hemisphere infarction. Stroke 1994;25:113-116.
14. Brosnan MJ, Clark JS, Jeffs B, Negrin CD, Van Vooren P, Arribas SM, Carswell H, Aitman TJ, Szpirer C, Macrae IM, Dominiczak AF: Genes encoding atrial and brain natriuretic peptides as candidates for sensitivity to brain ischemia in stroke-prone hypertensive rats. Hypertension 1999;33(part II):290-297.
15. Richards AM, Grozier IG, Holmes SJ, Espiner EA, Yandle TG, Frampton C: Brain natriuretic peptide: Natriuretic and endocrine effects in essential hypertension. J Hypertens 1993;11: 163-170.
16. La Villa G, Bisi G, Lazzeri C, Fronzaroli C, Stefani L, Barletta G, Del Bene R, Messeri G, Strazzulla G, Franchi F: Cardiovascular effects of brain natriuretic peptide in essential hypertension. Hypertension 1995;25:1053-1057.
17. La Villa G, Stefani L, Lazzeri C, Zurli C, Guerra CT, Barletta G, Bandinelli R, Strazzulla G, Franchi F: Acute effects of physiological increments of brain natriuretic peptide in humans. Hypertension 1995;26:628-633.
18. Janssen WMT, De Zeeuw D, Van Der Hem GK, De Jong PE: Antihypertensive effect of a 5-day infusion of atrial natriuretic factor in humans. Hypertension 1989;13:640-646.
19. Shimizu H, Murakami Y, Inoue S, Ohta Y, Nakamura K, Katoh H, Sakane T, Takahashi N, Ohata S, Sugamori T, Ishibashi Y, Shimada T: High plasma brain natriuretic polypeptide level as a marker of risk for thromboembolism in patients with nonvalvular atrial fibrillation. Stroke 2002;33:1005-1010.